Abstract
No public abstract is available from the verified source records.
Thijs T. W. van Herpt, Saskia A. M. van de Schans, Harm Reinout Haak, D.J. van Spronsen, Marcus Wouter Dercksen, Maryska L.G. Janssen-Heijnen
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Disease burden of diabetes mellitus type II in the Netherlands: incidence, prevalence and mortality
2001
The growing burden of diabetes mellitus in the US elderly population
10.1001/archinternmed.2007.35 · 2008
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program
10.1634/theoncologist.12-1-20 · 2007
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
10.1016/j.ejca.2007.12.015 · 2008
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis
10.1001/jama.2008.824 · 2008
Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach
10.1016/j.critrevonc.2005.04.008 · 2005
A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index
10.1111/j.1365-2141.2005.05508.x · 2005
Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkin's lymphoma
10.1097/01.cej.0000236253.93984.8f · 2007
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis
10.1002/ijc.22532 · 2007
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry
10.1016/j.ejca.2005.01.010 · 2005
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy
10.1200/jco.1995.13.10.2530 · 1995
Therapy of follicular lymphoma
10.1007/s00108-007-1804-2 · 2007
Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario
10.1016/j.ctrv.2006.10.005 · 2007
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
2006
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
10.1056/nejmoa011795 · 2002
Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective
2005
Chemotherapy-induced peripheral neuropathy
10.1007/pl00007853 · 2002
Doxorubicin (adriamycin) cardiomyopathy
1983
A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data
10.1016/s0895-4356(98)00154-1 · 1999
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
10.1016/0021-9681(87)90171-8 · 1987
Standards of medical care in diabetes-2010
2010
Unresolved referenced work
2008
Toxicity and response criteria of the Eastern Cooperative Oncology Group
10.1097/00000421-198212000-00014 · 1982
Cancer Therapy Evaluation Program
2006
Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas
1977
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
10.1200/jco.1999.17.4.1244 · 1999
Follicular lymphoma international prognostic index
10.1182/blood-2003-12-4434 · 2004
The International Non-Hodgkin's Lymphoma Prognostic Factors Project
1993
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
10.2337/diacare.27.5.1047 · 2004
Prevalence and incidence of Type 2 diabetes and its complications 1996–2003—estimates from a Swedish population-based study
10.1111/j.1464-5491.2008.02541.x · 2008
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
10.2337/dc08-1296 · 2009
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma
10.1093/annonc/mdm541 · 2008
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study
10.1200/jco.2004.03.213 · 2004
No additional external references are available.